Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05812105 · ClinicalTrials.gov registry record · NA
Improving the Mobility of Transportation Disadvantaged Older Adults
A NA study, sponsored by The University of Texas at Arlington.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05812105: Completed NA study, sponsored by The University of Texas at Arlington.
NCT05812105 is a NA study that has completed, run by The University of Texas at Arlington. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05812105, a NA study, has completed, sponsored by The University of Texas at Arlington.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The primary objective of the research was to improve mobility for transportation-disadvantaged older adults by expanding the scope of the existing Healthy Buddy Program, to accommodate an aging Spanish-speaking population in the U.S.
Primary Outcome
The title of the scale is Brief Older People's Quality of Life questionnaire. It is the short, 13-item version of the original Older People's Quality of Life questionnaire. Each of the 13 items is scored Strongly agree=5, Agree=4, Neither=3, Disagree=2, Strongly disagree=1. The items are summed for a total score, so that higher scores represented higher quality of life. The score ranges from 13 to 65.
Interventions
- OTHER Healthy Buddy Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-10-23 |
| Est. Completion | 2021-05-06 |
| Phase | NA |
What the finished NCT05812105 record still lists
NCT05812105 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Healthy Buddy Program is the first listed.
NCT05812105 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05812105 about?
NCT05812105 is a clinical study titled "Improving the Mobility of Transportation Disadvantaged Older Adults". The primary objective of the research was to improve mobility for transportation-disadvantaged older adults by expanding the scope of the existing Healthy Buddy Program, to accommodate an aging Spanish-speaking population in the U.S.
What is the current status of trial NCT05812105?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2020-10-23. Estimated completion is 2021-05-06.
What interventions are being tested in trial NCT05812105?
The interventions under investigation include: Healthy Buddy Program (OTHER).
Who is sponsoring clinical trial NCT05812105?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05812105's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI